thousands of women whose breast cancer has become resistant to standard treatment could benefit from a new drug combination , claim researchers.
it is hoped the new approach will target cancer stem cells that evade conventional drugs and cause the tumour to re-grow.
cancer that has spread and is incurable , known as secondary breast cancer , kills 1,000 women in uk every month.
it targets cancer cells that evade conventional drugs and cause tumours to re-grow they are testing the drug sulforadex in the most common type of breast cancer , affecting 70 per cent of patients